메뉴 건너뛰기




Volumn 56, Issue 8, 2011, Pages 2423-2431

Medication nonadherence with long-term management of patients with hepatitis B e antigen-negative chronic hepatitis B

Author keywords

Adefovir dipivoxil; Entecavir; HBeAg negative; Nonadherence; Outcome

Indexed keywords

ADEFOVIR DIPIVOXIL; ENTECAVIR; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

EID: 79960939356     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1610-5     Document Type: Article
Times cited : (50)

References (32)
  • 1
    • 0030707941 scopus 로고    scopus 로고
    • Hepatitis B virus infection
    • DOI 10.1056/NEJM199712113372406
    • Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733-1745. (Pubitemid 27527771)
    • (1997) New England Journal of Medicine , vol.337 , Issue.24 , pp. 1733-1745
    • Lee, W.M.1
  • 2
    • 1542515092 scopus 로고    scopus 로고
    • Chronic Hepatitis B: Update of Recommendations
    • DOI 10.1002/hep.20110
    • Lok AS, McMahon BJ. Chronic hepatitis B: Update of recommendations. Hepatology. 2004;39:857-861. (Pubitemid 38337668)
    • (2004) Hepatology , vol.39 , Issue.3 , pp. 857-861
    • Lok, A.S.F.1    McMahon, B.J.2
  • 3
    • 24344435917 scopus 로고    scopus 로고
    • Epidemiology and natural history of hepatitis B
    • DOI 10.1055/s-2005-915644
    • McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis. 2005;25:3-8. (Pubitemid 41254588)
    • (2005) Seminars in Liver Disease , vol.25 , Issue.SUPPL. 1 , pp. 3-8
    • McMahon, B.J.1
  • 4
    • 1642410856 scopus 로고    scopus 로고
    • Hepatitis B virus epidemiology, disease burden, treatment, arid current and emerging prevention and control measures
    • DOI 10.1046/j.1365-2893.2003.00487.x
    • Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97-107. (Pubitemid 38365759)
    • (2004) Journal of Viral Hepatitis , vol.11 , Issue.2 , pp. 97-107
    • Lavanchy, D.1
  • 5
    • 57149091722 scopus 로고    scopus 로고
    • A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 Update
    • Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008;6:1315-1341.
    • (2008) Clin Gastroenterol Hepatol , vol.6 , pp. 1315-1341
    • Keeffe, E.B.1    Dieterich, D.T.2    Han, S.H.3
  • 6
    • 70349240414 scopus 로고    scopus 로고
    • Chronic hepatitis B: Update 2009
    • Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661-662.
    • (2009) Hepatology , vol.50 , pp. 661-662
    • Lok, A.S.1    McMahon, B.J.2
  • 7
    • 34247626014 scopus 로고    scopus 로고
    • Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B
    • Dai CY, Chuang WL, Hsieh MY, et al. Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B. Antiviral Res. 2007;75:146-151.
    • (2007) Antiviral Res , vol.75 , pp. 146-151
    • Dai, C.Y.1    Chuang, W.L.2    Hsieh, M.Y.3
  • 8
    • 0038276960 scopus 로고    scopus 로고
    • Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature
    • DOI 10.1053/jhep.2003.50208
    • Mommeja-Marin H, Mondou E, Blum MR, Rousseau F. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology. 2003;37:1309-1319. (Pubitemid 36667310)
    • (2003) Hepatology , vol.37 , Issue.6 , pp. 1309-1319
    • Mommeja-Marin, H.1    Mondou, E.2    Blum, M.R.3    Rousseau, F.4
  • 10
    • 0141841678 scopus 로고    scopus 로고
    • Medication compliance feedback and monitoring in a clinical trial: Predictors and outcomes
    • DOI 10.1046/j.1524-4733.2003.65269.x
    • Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J. Medication compliance feedback and monitoring in a clinical trial: Predictors and outcomes. Value Health. 2003;6:566-573. (Pubitemid 37187719)
    • (2003) Value in Health , vol.6 , Issue.5 , pp. 566-573
    • Cramer, J.A.1    Rosenheck, R.2    Kirk, G.3    Krol, W.4    Krystal, J.5
  • 14
    • 78649636795 scopus 로고    scopus 로고
    • Study of adherence comes to the treatment of chronic hepatitis B
    • Lee M, Keeffe EB. Study of adherence comes to the treatment of chronic hepatitis B. J Hepatol. 2011;54:6-8.
    • (2011) J Hepatol , vol.54 , pp. 6-8
    • Lee, M.1    Keeffe, E.B.2
  • 19
    • 66149115173 scopus 로고    scopus 로고
    • Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy
    • Tenney DJ, Rose RE, Baldick CJ, et al. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy. Hepatology. 2009;49:1503-1514.
    • (2009) Hepatology , vol.49 , pp. 1503-1514
    • Tenney, D.J.1    Rose, R.E.2    Baldick, C.J.3
  • 20
    • 70349230970 scopus 로고    scopus 로고
    • Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil
    • Ha NB, Garcia RT, Trinh HN, et al. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. Hepatology. 2009;50:727-734.
    • (2009) Hepatology , vol.50 , pp. 727-734
    • Ha, N.B.1    Garcia, R.T.2    Trinh, H.N.3
  • 22
    • 0036719562 scopus 로고    scopus 로고
    • Patient adherence and medical treatment outcomes: A meta-analysis
    • DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: A meta-analysis. Med Care. 2002;40:794-811.
    • (2002) Med Care , vol.40 , pp. 794-811
    • DiMatteo, M.R.1    Giordani, P.J.2    Lepper, H.S.3    Croghan, T.W.4
  • 23
    • 0034121211 scopus 로고    scopus 로고
    • Long-term patient adherence to antiretroviral therapy
    • Ostrop NJ, Hallett KA, Gill MJ. Long-term patient adherence to antiretroviral therapy. Ann Pharmacother. 2000;34:703-709. (Pubitemid 30395767)
    • (2000) Annals of Pharmacotherapy , vol.34 , Issue.6 , pp. 703-709
    • Ostrop, N.J.1    Hallett, K.A.2    Gill, M.J.3
  • 25
    • 78649629222 scopus 로고    scopus 로고
    • Discrepancy between virological breakthrough and confirmed genotypic resistance in chronic hepatitis B patients receiving nucleos(t)ide analogue therapy in clinical practice
    • abstract
    • Hongthanakorn C, Chotiyaputta W, Oberhelman K, et al. Discrepancy between virological breakthrough and confirmed genotypic resistance in chronic hepatitis B patients receiving nucleos(t)ide analogue therapy in clinical practice. Gastroenterology. 2010;138:S793 [abstract].
    • (2010) Gastroenterology , vol.138
    • Hongthanakorn, C.1    Chotiyaputta, W.2    Oberhelman, K.3
  • 26
    • 0032808202 scopus 로고    scopus 로고
    • The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
    • California Collaborative Treatment Group
    • Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS. 1999;13:1099-1107.
    • (1999) AIDS , vol.13 , pp. 1099-1107
    • Haubrich, R.H.1    Little, S.J.2    Currier, J.S.3
  • 27
    • 0030578667 scopus 로고    scopus 로고
    • Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications
    • DOI 10.1016/S0140-6736(96)01073-2
    • Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383-386. (Pubitemid 26261515)
    • (1996) Lancet , vol.348 , Issue.9024 , pp. 383-386
    • Haynes, R.B.1    McKibbon, K.A.2    Kanani, R.3
  • 28
    • 0032135104 scopus 로고    scopus 로고
    • Effectiveness of Interventions to Improve Patient Compliance a Meta-Analysis
    • Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: A meta-analysis. Med Care. 1998;36:1138-1161. (Pubitemid 128456406)
    • (1998) Medical Care , vol.36 , Issue.8 , pp. 1138-1161
    • Roter, D.L.1    Hall, J.A.2    Merisca, R.3    Nordstrom, B.4    Cretin, D.5    Svarstad, B.6
  • 29
    • 34249010801 scopus 로고    scopus 로고
    • Health beliefs, disease severity, and patient adherence: A meta-analysis
    • DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: A meta-analysis. Med Care. 2007;45:521-528.
    • (2007) Med Care , vol.45 , pp. 521-528
    • DiMatteo, M.R.1    Haskard, K.B.2    Williams, S.L.3
  • 30
    • 0034457843 scopus 로고    scopus 로고
    • Factors affecting adherence to antiretroviral therapy
    • DOI 10.1086/313849
    • Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30:S171-S176. (Pubitemid 32268984)
    • (2000) Clinical Infectious Diseases , vol.30 , Issue.SUPPL. 2
    • Chesney, M.A.1
  • 31
    • 78649631236 scopus 로고    scopus 로고
    • Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
    • Chotiyaputta W, Peterson C, Ditah FA, Goodwin D, Lok AS. Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B. J Hepatol. 2011;54:12-18.
    • (2011) J Hepatol , vol.54 , pp. 12-18
    • Chotiyaputta, W.1    Peterson, C.2    Ditah, F.A.3    Goodwin, D.4    Lok, A.S.5
  • 32
    • 0035885062 scopus 로고    scopus 로고
    • Strategies for optimizing adherence to highly active antiretroviral therapy: Lessons from research and clinical practice
    • DOI 10.1086/322698
    • Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice. Clin Infect Dis. 2001;33:865-872. (Pubitemid 32831844)
    • (2001) Clinical Infectious Diseases , vol.33 , Issue.6 , pp. 865-872
    • Stone, V.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.